BA.1, BA.2 and BA.2.75 variants show comparable replication kinetics, reduced impact on epithelial barrier and elicit cross-neutralizing antibodies - Singh, Janmejay; Anantharaj, Anbalagan; Panwar, Aleksha; Rani, Chitra; Bhardwaj, Monika; Kumar, Parveen; Chattopadhyay, Partha; Devi, Priti; Maurya, Ranjeet; Mishra, Pallavi; Pandey, Anil Kumar; Pandey, Rajesh; et al. (PLoS pathogens, 2023)
Keywords: Antibodies; Antibodies, Neutralizing; Antibodies, Viral; Antibody response; Biological response modifiers; Biology and Life Sciences; Broadly Neutralizing Antibodies; Cell culture; Copper; Coronaviruses; COVID-19; COVID-19 vaccines; Cross-protection; Disease susceptibility; Disease transmission; Epithelium; Genetic aspects; Growth kinetics; Health aspects; Humans; Infection; Infections; Interferon; Interferons - genetics; Iron; Kinetics; Medicine and Health Sciences; Neutralization; Neutralizing; Pandemics; Physiological aspects; Replication; Research and Analysis Methods; RNA polymerase; SARS-CoV-2 - genetics; Severe acute respiratory syndrome coronavirus 2; Viral antibodies; Viral diseases; Virulence; Virus research; Viruses; Zinc; India